Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| aTYR PHARMA INC | 153,553 | reported | 04 Feb 2026 | tx 47+6,122,885−50,339 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | SALE | aTYR PHARMA INC | 3,745 | 0.98 USD | |
| 03 Feb 2026 | EXERCISE | aTYR PHARMA INC | 10,375 | — | |
| 03 Feb 2026 | EXERCISE | aTYR PHARMA INC | 10,375 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | aTYR PHARMA INC | 1,500,000 | 0.00 USD | deriv |
| 03 Feb 2025 | EXERCISE | aTYR PHARMA INC | 10,375 | — | |
| 03 Feb 2025 | EXERCISE | aTYR PHARMA INC | 10,375 | 0.00 USD | deriv |
| 08 Jan 2025 | GRANT_AWARD | aTYR PHARMA INC | 1,000,000 | 0.00 USD | deriv |
| 31 May 2024 | PURCHASE | aTYR PHARMA INC | 20,000 | 1.81 USD | |
| 05 Feb 2024 | EXERCISE | aTYR PHARMA INC | 10,375 | — | |
| 05 Feb 2024 | EXERCISE | aTYR PHARMA INC | 10,375 | 0.00 USD | deriv |
| 05 Jan 2024 | GRANT_AWARD | aTYR PHARMA INC | 600,000 | 0.00 USD | deriv |
| 12 Dec 2023 | PURCHASE | aTYR PHARMA INC | 12,000 | 1.18 USD | |
| 11 Dec 2023 | PURCHASE | aTYR PHARMA INC | 3,000 | 1.17 USD | |
| 10 Nov 2023 | PURCHASE | aTYR PHARMA INC | 1,422 | 1.14 USD | anomaly |
| 13 Nov 2023 | PURCHASE | aTYR PHARMA INC | 13,578 | 1.11 USD | |
| 28 Jul 2023 | PURCHASE | aTYR PHARMA INC | 15,000 | 2.01 USD | |
| 16 Feb 2023 | GRANT_AWARD | aTYR PHARMA INC | 336,096 | 0.00 USD | deriv |
| 03 Feb 2023 | EXERCISE | aTYR PHARMA INC | 10,375 | — | |
| 03 Feb 2023 | EXERCISE | aTYR PHARMA INC | 10,375 | 0.00 USD | deriv |
| 21 Nov 2022 | PURCHASE | aTYR PHARMA INC | 10,000 | 2.14 USD | |
| 01 Jul 2022 | PURCHASE | aTYR PHARMA INC | 15,000 | 2.88 USD | |
| 24 May 2022 | GRANT_AWARD | aTYR PHARMA INC | 516,280 | 0.00 USD | deriv |
| 03 Feb 2022 | GRANT_AWARD | aTYR PHARMA INC | 83,000 | 0.00 USD | deriv |
| 03 Feb 2022 | GRANT_AWARD | aTYR PHARMA INC | 41,500 | 0.00 USD | deriv |
| 07 Jan 2022 | PURCHASE | aTYR PHARMA INC | 5,000 | 6.76 USD |